Patents Assigned to Sessions Pharmaceuticals Inc.
-
Publication number: 20140163505Abstract: A foam-based wound dressing for covering a wound on an extremity. The wound dressing includes a composite body having two distinct layers joined along a portion of their perimeters to form a least one open end. Each layer includes a hydrophilic foam matrix attached to a urethane film.Type: ApplicationFiled: April 4, 2012Publication date: June 12, 2014Applicant: SESSIONS PHARMACEUTICALS INC.Inventor: Leslie Clemens
-
Patent number: 8486454Abstract: The present invention provides a method of attenuating the formation or reducing the severity of neurogenic pain in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of neurogenic pain.Type: GrantFiled: September 29, 2006Date of Patent: July 16, 2013Assignee: Sessions Pharmaceuticals Inc.Inventors: Robert W. Sessions, Alan R. Kahn
-
Patent number: 8101206Abstract: The present invention provides a method of attenuating the formation or reducing the severity of swelling and/or inflammation in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of swelling and/or inflammation.Type: GrantFiled: September 29, 2006Date of Patent: January 24, 2012Assignee: Sessions Pharmaceuticals Inc.Inventors: Robert W. Sessions, Alan R. Kahn
-
Patent number: 7875294Abstract: The present invention provides a method of attenuating the formation or reducing the severity of a bruise in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of bruising.Type: GrantFiled: September 28, 2006Date of Patent: January 25, 2011Assignee: Sessions Pharmaceuticals Inc.Inventors: Robert W. Sessions, Roger Sessions, legal representative, Alan R. Kahn
-
Publication number: 20100267640Abstract: The present invention provides a method of attenuating the formation or reducing the severity of neurogenic swelling and/or neurogenic inflammation in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of neurogenic swelling and/or neurogenic inflammation.Type: ApplicationFiled: April 26, 2010Publication date: October 21, 2010Applicant: Sessions Pharmaceuticals, Inc.Inventors: Robert W. Sessions, Alan R. Kahn
-
Patent number: 7709005Abstract: The present invention provides a method of attenuating the formation or reducing the severity of neurogenic swelling and/or neurogenic inflammation in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of neurogenic swelling and/or neurogenic inflammation.Type: GrantFiled: September 29, 2006Date of Patent: May 4, 2010Assignee: Sessions Pharmaceuticals Inc.Inventors: Robert W. Sessions, Alan R. Kahn
-
Publication number: 20100106122Abstract: A wound dressing including a composite body of predetermined length adapted for insertion into a wound cavity. The composite body includes a hydrophilic foam matrix. A first layer of polymer-based mesh is disposed at a first position within the foam matrix and at least a second layer of polymer-based mesh is disposed at a second position within the foam matrix in spaced apart opposing relation to the first layer of polymer-based mesh. The first layer of polymer-based mesh and the second layer of polymer-based mesh are in sandwiching relation to a foam core. The wound dressing provides among other advantages strength and substantially enhanced wicking action.Type: ApplicationFiled: October 26, 2009Publication date: April 29, 2010Applicant: SESSIONS PHARMACEUTICALS INC.Inventor: Leslie CLEMENS
-
Patent number: 7625585Abstract: The present invention provides a method of attenuating the formation or reducing the severity of a neurogenic bruise in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of bruising.Type: GrantFiled: May 25, 2006Date of Patent: December 1, 2009Assignee: Sessions Pharmaceuticals Inc.Inventors: Robert W. Sessions, Alan R. Kahn
-
Patent number: D636881Type: GrantFiled: February 10, 2009Date of Patent: April 26, 2011Assignee: Sessions Pharmaceuticals Inc.Inventors: Leslie Clemens, John J. Newton, Jr.